Vaccination with GM2-KLH-QS21 does not improve outcome stage II melanomas patients in EORTC study
9/17/2013
Results of an EORTC study published in the Journal of Clinical Oncology show that vaccination with GM2/KLH-QS-21 does not benefit patients with stage II melanoma. Vaccination with GM2/KLH-QS-21 stimulates the production of antibodies to the GM2 ganglioside, an antigen expressed by many melanomas...
Vaccination with GM2-KLH-QS21 does not improve outcome stage II melanomas patients in EORTC study
9/17/2013
Results of an EORTC study published in the Journal of Clinical Oncology show that vaccination with GM2/KLH-QS-21 does not benefit patients with stage II melanoma. Vaccination with GM2/KLH-QS-21 stimulates the production of antibodies to the GM2 ganglioside, an antigen expressed by many melanomas...
New approach subtypes cancers by shared genetic effects; a step toward personalized medicine
9/17/2013
Cancer tumors almost never share the exact same genetic mutations, a fact that has confounded scientific efforts to better categorize cancer types and develop more targeted, effective treatments...
UNC researchers identify a new pathway that triggers septic shock
9/17/2013
The body's immune system is set up much like a home security system; it has sensors on the outside of cells that act like motion detectors - floodlights - that click on when there's an intruder rustling in the bushes, bacteria that seem suspect. For over a decade researchers have known about one group of external sensors called Toll-like receptors that detect when bacteria are nearby...
Test could identify which prostate cancers require treatment
9/16/2013
The level of expression of three genes associated with aging can be used to predict whether seemingly low-risk prostate cancer will remain slow-growing, according to researchers at the Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center...
T-rays offer potential for earlier diagnosis of melanoma
9/16/2013
The technology that peeks underneath clothing at airport security screening check points has great potential for looking underneath human skin to diagnose cancer at its earliest and most treatable stages, a scientist has said...
Tiny diamonds to boost treatment of chemoresistant leukemia
9/16/2013
By binding multiple molecules of a common leukemia drug with nanodiamonds, scientists from the National University of Singapore (NUS) and University of California, Los Angeles (UCLA) managed to boost the delivery of the drug to leukemic cells and retain the drug within the cells to combat the cancer...
Test could identify which prostate cancers require treatment
9/16/2013
The level of expression of three genes associated with aging can be used to predict whether seemingly low-risk prostate cancer will remain slow-growing, according to researchers at the Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center...
T-rays offer potential for earlier diagnosis of melanoma
9/16/2013
The technology that peeks underneath clothing at airport security screening check points has great potential for looking underneath human skin to diagnose cancer at its earliest and most treatable stages, a scientist has said...
Tiny diamonds to boost treatment of chemoresistant leukemia
9/16/2013
By binding multiple molecules of a common leukemia drug with nanodiamonds, scientists from the National University of Singapore (NUS) and University of California, Los Angeles (UCLA) managed to boost the delivery of the drug to leukemic cells and retain the drug within the cells to combat the cancer...